Purple Biotech 과거 수익 실적
과거 기준 확인 0/6
Purple Biotech's earnings have been declining at an average annual rate of -7.9%, while the Pharmaceuticals industry saw earnings growing at 10.3% annually. Revenues have been declining at an average rate of 61.3% per year.
주요 정보
-7.9%
수익 성장률
36.0%
EPS 성장률
Pharmaceuticals 산업 성장 | 35.1% |
매출 성장률 | -61.3% |
자기자본 수익률 | -54.8% |
순이익 | n/a |
최근 수익 업데이트 | 30 Jun 2024 |
최근 과거 실적 업데이트
Recent updates
We're A Little Worried About Purple Biotech's (TLV:PPBT) Cash Burn Rate
Mar 07Can Purple Biotech (TLV:PPBT) Afford To Invest In Growth?
Oct 30Will Purple Biotech (TLV:PPBT) Spend Its Cash Wisely?
Jul 17Here's Why We're Watching Purple Biotech's (TLV:PPBT) Cash Burn Situation
Mar 13Is Purple Biotech (TLV:PPBT) In A Good Position To Deliver On Growth Plans?
Nov 27Is Purple Biotech (TLV:PPBT) In A Good Position To Deliver On Growth Plans?
Jul 21Purple Biotech (TLV:PPBT) Is In A Good Position To Deliver On Growth Plans
Mar 25Companies Like Purple Biotech (TLV:PPBT) Are In A Position To Invest In Growth
Dec 09Purple Biotech (TLV:PPBT) Is In A Good Position To Deliver On Growth Plans
May 28We Think Purple Biotech (TLV:PPBT) Can Afford To Drive Business Growth
Feb 11If You Had Bought Purple Biotech's (TLV:KTOV) Shares Five Years Ago You Would Be Down 90%
Dec 21수익 및 비용 분석
Purple Biotech 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역
날짜 | 수익 | 수익 | G+A 비용 | R&D 비용 |
---|---|---|---|---|
30 Jun 24 | 0 | -16 | 4 | 16 |
31 Mar 24 | 0 | -19 | 4 | 17 |
31 Dec 23 | 0 | -20 | 5 | 17 |
30 Sep 23 | 0 | -21 | 6 | 17 |
30 Jun 23 | 0 | -21 | 6 | 15 |
31 Mar 23 | 0 | -19 | 6 | 14 |
31 Dec 22 | 0 | -22 | 6 | 16 |
30 Sep 22 | 0 | -20 | 6 | 15 |
30 Jun 22 | 0 | -19 | 6 | 13 |
31 Mar 22 | 0 | -19 | 6 | 13 |
31 Dec 21 | 0 | -18 | 6 | 12 |
30 Sep 21 | 0 | -13 | 7 | 11 |
30 Jun 21 | -1 | -11 | 7 | 11 |
31 Mar 21 | 1 | -21 | 7 | 11 |
31 Dec 20 | 0 | -29 | 6 | 7 |
30 Sep 20 | 1 | -30 | 5 | 6 |
30 Jun 20 | 1 | -31 | 4 | 4 |
31 Mar 20 | 1 | -18 | 5 | 3 |
31 Dec 19 | 0 | -5 | 4 | 2 |
30 Sep 19 | 1 | -4 | 4 | 3 |
30 Jun 19 | 1 | -3 | 3 | 4 |
31 Mar 19 | 1 | -4 | 4 | 5 |
31 Dec 18 | 1 | -5 | 4 | 5 |
30 Sep 18 | 1 | -8 | 5 | 5 |
30 Jun 18 | 1 | -11 | 6 | 5 |
31 Mar 18 | 1 | -12 | 6 | 5 |
31 Dec 17 | 0 | -12 | 6 | 5 |
30 Sep 17 | 0 | -14 | 5 | 5 |
30 Jun 17 | 0 | -15 | 4 | 5 |
31 Mar 17 | 0 | -14 | 4 | 4 |
31 Dec 16 | 0 | -12 | 3 | 4 |
30 Sep 16 | 0 | -9 | 3 | 4 |
30 Jun 16 | 0 | -6 | 2 | 4 |
31 Mar 16 | 0 | -5 | 2 | 3 |
31 Dec 15 | 0 | -4 | 2 | 3 |
30 Sep 15 | 0 | -4 | 1 | 2 |
30 Jun 15 | 0 | -4 | 1 | 2 |
31 Mar 15 | 0 | -5 | 1 | 3 |
31 Dec 14 | 0 | -5 | 1 | 3 |
30 Sep 14 | 0 | -5 | 1 | 3 |
30 Jun 14 | 0 | -6 | 1 | 2 |
31 Mar 14 | 0 | -4 | 1 | 1 |
양질의 수익: PPBT is currently unprofitable.
이익 마진 증가: PPBT is currently unprofitable.
잉여현금흐름 대 수익 분석
과거 수익 성장 분석
수익추이: PPBT is unprofitable, and losses have increased over the past 5 years at a rate of 7.9% per year.
성장 가속화: Unable to compare PPBT's earnings growth over the past year to its 5-year average as it is currently unprofitable
수익 대 산업: PPBT is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (7.1%).
자기자본 수익률
높은 ROE: PPBT has a negative Return on Equity (-54.84%), as it is currently unprofitable.